We are excited to share that our lab has had a productive academic year! Join us in celebrating these accomplishments.
The following grants have been awarded to our research group:
From The V Foundation-“Targeting the Hippo pathway in RAS-driven rhabdomyosarcoma (rERMS)”
From the Schiffman Foundation-“Use of 3D sphere cultures to investigate stemness properties of rhabdomyosarcoma”
From St. Baldrick’s Foundation (Research Award)- “Identification and validation of the PAX3-FOXO1 protein interactome”
From the Kate Amato Foundation-“Evaluation of the lncRNA KCNQ1OT1 and its binding proteins as pre-clinical therapeutic targets in embryonal rhabdomyosarcoma”
From Children’s Miracle Network Hospitals (Derfner Foundation Research Award, to Alex Kovach PhD)- “Preclinical evaluation of HES1 inhibition in the childhood cancer rhabdomyosarcoma”
The following papers have been accepted for publication:
RASSF4 is required for skeletal muscle differentiation. Lin YT, Deel MD, Linardic CM. Cell Biol Int. 2019 Sep 11. doi: 10.1002/cbin.11238.
Soft Tissue Sarcoma Cancer Stem Cells: An Overview. Genadry KC, Pietrobono S, Rota R, Linardic CM. Front Oncol. 2018 Oct 26;8:475. doi: 10.3389/fonc.2018.00475. eCollection 2018. Review.
Cheers to forward progress!
